Background: The PROMIS Global-10 is a 10-item questionnaire that assesses general health-related quality of life. There is a paucity of research on the utility of the PROMIS Global-10 in the evaluation of orthopedic conditions. The aim of this study is to compare PROMIS Global-10 and legacy shoulder-specific patient-reported outcome measures (PROMs) in patients undergoing total shoulder arthroplasty (TSA) for shoulder arthritis.

Methods: This retrospective cohort study included patients who underwent TSA for shoulder arthritis and completed preoperative and 1-year postoperative surveys. Primary outcome measures were the physical (PROMIS-P) and mental (PROMIS-M) components of PROMIS Global-10. The legacy PROMs included the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES) score, the Single Assessment Numeric Evaluation (SANE), and the Shoulder Activity Scale (SAS). Analyses included postoperative changes for each outcome, correlations between measures and a responsiveness assessment.

Results: A total of 170 patients met inclusion criteria. Average age and body mass index were 67.7 ± 7.8 years and 28.0 ± 4.9, respectively. All legacy PROMs and PROMIS-P were significantly higher at 1-year follow-up compared with the preoperative level (P < .0001), whereas PROMIS-M did not change (P = .06). Preoperatively, both PROMIS components were either poorly correlated with all legacy PROMs (r < .04, P < .05) or not correlated at all (P > .05). Postoperatively, PROMIS-M was poorly correlated with all legacy PROMs (r < .04, P < .01), whereas PROMIS-P had fair correlation with ASES (r = .5, P < .0001) and poor correlation with SANE and SAS (r < .04, P < .01). A floor effect was observed for SANE, and SANE and ASES had a ceiling effect. The effect sizes for SANE and ASES were high (d = 2.01 and 2.39 respectively), whereas the effect size for SAS was moderate (d = 0.65), and the effect sizes for the PROMIS measures were small (d < .5). ASES was the most responsive measure and PROMIS-M was the least responsive.

Conclusion: PROMIS Global-10 had limited correlation with legacy PROMs and was less responsive at 1-year follow-up in patients following TSA. The Global-10 appears to have limited utility in the evaluation of patients with shoulder arthritis both preoperatively and after TSA.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jse.2020.10.021DOI Listing

Publication Analysis

Top Keywords

promis global-10
24
legacy proms
20
shoulder
9
promis
8
patients undergoing
8
undergoing total
8
total shoulder
8
shoulder arthroplasty
8
global-10 legacy
8
outcome measures
8

Similar Publications

The doctor-patient perception mismatch: Improving approaches to assessing outcomes after ischemic stroke treated with reperfusion therapy.

J Clin Neurosci

February 2025

Cooper Neurological Institute, Cooper University Hospital, 1 Cooper Plaza, Camden, NJ, USA; Cooper Medical School of Rowan University (CMSRU), 401 S Broadway, Camden, NJ, USA; Center for Neuroinflammation at CMSRU, 401 S Broadway, Camden, NJ, USA. Electronic address:

The long-term effects of ischemic stroke on cognition and mental health are not reflected in traditional outcome metrics, like the modified Rankin Scale (mRS) for functional independence. Consequently, this may lead to mismatches in perceptions of overall recovery, despite otherwise qualifying as having good functional outcomes (mRS 0-2). In our multicenter, multinational analysis, we aim to describe the prevalence of, and factors associated with, patient-reported cognitive impairment despite achieving good functional outcomes.

View Article and Find Full Text PDF

Background: The purpose of this study is to analyze the relationship between discharge opioids after operative treatment of carpometacarpal (CMC) arthritis and patient-reported outcomes (PROs) over a 6-month episode of care.

Methods: A total of 172 patients met inclusion criteria for this study. Patient-reported outcomes including patient-reported wrist/hand evaluation (PRWHE), single assessment numeric evaluation, and PRO measurement information system (PROMIS) global-10 questionnaires were collected prospectively and stored in an electronic data capture system until review for the purpose of this study.

View Article and Find Full Text PDF

Preoperative CT Scans Prior to Distal Tibial Intramedullary Nailing Do not Change Treatment Decisions or Surgical Outcomes.

J Am Acad Orthop Surg

October 2024

From the Department of Orthopaedic Surgery, University of Minnesota, Minneapolis, MN (Comadoll, Paull, Boike, Swenson, Wojahn, and Nguyen), and the Department of Orthopaedic Surgery, Regions Hospital, Saint Paul, MN (Paull, Swenson, Wojahn, and Nguyen).

Article Synopsis
  • Distal tibia shaft fractures often accompany posterior malleolar fractures (PMFs), leading to routine preoperative ankle CT scans to assess damage.
  • A study analyzed data from 124 patients with these fractures, comparing outcomes between those who received CT scans and those who did not, but found no significant differences in key outcomes.
  • While CT scans helped identify some PMFs that weren't visible on regular x-rays, they did not improve surgical efficiency or reduce complications related to PMFs.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the effects of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies on health-related quality of life (HRQoL) and well-being among people with cystic fibrosis (PwCF) and their caregivers.
  • - Results show that adult PwCF currently on modulator therapy experience better physical and mental health compared to those who have stopped or never used the treatments, but some (23%) report declines in mental well-being.
  • - The findings aim to inform future research, policy, and communication efforts that could enhance the well-being of PwCF by understanding their experiences with modulator therapies.
View Article and Find Full Text PDF

Importance: Matched placebo interventions are complex and resource intensive. Recent evidence suggests matched placebos may not always be necessary. Previous studies have predominantly evaluated potential bias of nonmatched placebos (ie, differing on dose, frequency of administration, or formulation) in pain and mental health, but to date no systematic examination has been conducted in infectious disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!